1.12 USD
0.000.00%
盘后 1.13 0.00%
2026-09-16
市值
$66.26M
市盈率
—
EPS
-1.50
股息率
—
52 周区间
1.02 – 1.95
成交量
472.36K
Beta
1.28
目标价
2.00
52W 低 1.0252W 高 1.95
价格走势
公司简介
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company’s lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of αvß8 and αvß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics,...